External validation of the 4C Mortality Score for hospitalised patients with COVID-19 in the RECOVER network.

ABSTRACT:

Objectives

Estimating mortality risk in hospitalised SARS-CoV-2+ patients may help with choosing level of care and discussions with patients. The Coronavirus Clinical Characterisation Consortium Mortality Score (4C Score) is a promising COVID-19 mortality risk model. We examined the association of risk factors with 30-day mortality in hospitalised, full-code SARS-CoV-2+ patients and investigated the discrimination and calibration of the 4C Score. This was a retrospective cohort study of SARS-CoV-2+ hospitalised patients within the RECOVER (REgistry of suspected COVID-19 in EmeRgency care) network.

Setting

99 emergency departments (EDs) across the USA.

Participants

Patients ≥18 years old, positive for SARS-CoV-2 in the ED, and hospitalised.

Primary outcome

Death

SUBMITTER: Gordon AJ 

PROVIDER: S-EPMC9023850 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature